Quote | SpringWorks Therapeutics Inc. (NYSE:SWTX)
Last: | $ |
---|---|
Change Percent: | 9.36% |
Open: | $30.72 |
Close: | $33.30 |
High: | $34.35 |
Low: | $29.41 |
Volume: | 169,218 |
Last Trade Date Time: | 02/12/2020 04:43:31 pm |
News | SpringWorks Therapeutics Inc. (NYSE:SWTX)
2024-04-19 15:55:00 ET Summary SpringWorks Therapeutics received FDA approval for its oral gamma secretase inhibitor Ogsiveo for the treatment of desmoid tumors in November last year. Ogsiveo is the first therapy approved for desmoid tumors, with a market opportunity estimated at ...
STAMFORD, Conn., April 18, 2024 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a commercial-stage biopharmaceutical company focused on severe rare diseases and cancer, today announced that it will host a live conference call and webcast at 8:30 a.m. E.T. on Thursday, May 2, 20...
Message Board Posts | SpringWorks Therapeutics Inc. (NYSE:SWTX)
Subject | By | Source | When |
---|---|---|---|
10 years since last post on this board, | UKdude | investorshub | 05/24/2022 11:20:50 AM |
Solutia Commences Tender Offer to Acquire Southwall Technologies Inc. | BSWB | investorshub | 10/25/2011 4:21:31 PM |
Nice gap up | $King | investorshub | 10/09/2011 4:14:12 PM |
Solutia to Acquire Southwall Technologies Inc. | MWM | investorshub | 10/07/2011 12:58:06 PM |
It's a great thing they are on the | MWM | investorshub | 05/20/2011 1:58:03 PM |
News, Short Squeeze, Breakout and More Instantly...
SpringWorks Therapeutics Inc. Company Name:
SWTX Stock Symbol:
NYSE Market:
STAMFORD, Conn., April 18, 2024 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc. (NASDAQ:SWTX), a commercial-stage biopharmaceutical company f...
STAMFORD, Conn., April 18, 2024 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a commercial-stage biopharmaceutical company focused on severe rare diseases and cancer, today announced that it will host a live conference call and webcast at 8:30 a.m. E.T. on Thursday, May 2, 20...
2024-03-05 09:48:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...